BIOSW

BioPlus Acquisition Corp. [BIOSW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIOSW Stock Summary

In the News

BIOSW Financial details

Company Rating
-
Market Cap
209.07M
Income
11.85M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
17.69
Forward P/E
-
PEG
-0.13
P/S
-
P/B
1.82
P/C
-
P/FCF
-129.65
Quick Ratio
69.94
Current Ratio
0.1
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.28
EPS next Y
-
EPS next Q
-
EPS this Y
-138.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-70.59%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
9%
ROE
6%
ROC
-0.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.0E-4-0.0028
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
CMC.DE
META
AAPL
BRH.DE
APC.DE
Same Sector
IS3R.DE
HQL
UFMA.F
8732.T
UBUM.DE
Check Those
MESO
0GZB.L
6928.T
3201.T
ORBT
Similar Market Cap
FLKR
FIZN
NETM-B.ST
QDVC.DE
AFE.V

Company Profile

Financial Services Shell Companies
  • Market Capitalization 209.07M
  • CEO Mr. Jonathan M. N. Rigby MBA
  • Headquarters New York,NY,US
  • IPO Date 2022-01-24
  • Website https://bioplusspac.com

BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on companies in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.